India  

Coronavirus vaccine safe in early trial; hydroxychloroquine may increase death risk

Reuters Friday, 22 May 2020 ()
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
0
shares
ShareTweetSavePostSend
 
Video credit: Wochit - Published
News video: Coronavirus Vaccine From China Is Safe In Early Trial

Coronavirus Vaccine From China Is Safe In Early Trial 00:40

A coronavirus vaccine developed by CanSino Biologics Inc appears to be safe. It induced a rapid immune response in its first human trial, Reuters reports. This vaccine did not cause any serious adverse effects, though side effects such as fever were noted. Blood samples from the 108 vaccinated...

Related videos from verified sources

Risk of COVID-19 Transmission Inside vs. Outside: Explained [Video]

Risk of COVID-19 Transmission Inside vs. Outside: Explained

Risk of COVID-19 Transmission Inside vs. Outside: Explained With stay-at-home orders loosening across the country, it’s important to remember COVID-19 transmission can and will still happen. Here are..

Credit: Wibbitz Studio     Duration: 01:35Published
Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death [Video]

Study: COVID-19 Patients Treated With Hydroxychloroquine At Higher Risk Of Death

Business Insider reports that a coronavirus vaccine my not be ready until the end of 2021, according to Roche, the world's second-largest pharmaceutical company. He explained "According to the most..

Credit: Wochit     Duration: 00:26Published

You Might Like


Tweets about this